News
PODCAST EPISODE 315 Click here to watch the video version of this podcast. Retina specialists have limited imaging and surgical tools to visualize the…
Read MorePODCAST EPISODE 314 Click here to watch the video version of this podcast. Daniel Chao, MD, PhD, spent a lot of years in the lab…
Read MorePODCAST EPISODE 313 Click here to watch the video version of this podcast. A new generation of drug-delivery technology is emerging, with new refillable, absorbable, and…
Read MorePODCAST EPISODE 312 Click here to watch the video version of this podcast. Brian Strem, president and CEO of Kiora Pharmaceuticals, didn’t plan to become…
Read MorePODCAST EPISODE 311 Click here to watch the video version of this podcast. A college detour from medical school and into scientific research worked to…
Read MorePODCAST EPISODE 309 Click here to watch the video version of this podcast. Even the most experienced physicians encounter patients with conditions they can’t solve…
Read MoreEven the most groundbreaking device won’t go far if doctors can’t easily adopt it into their practice. PODCAST EPISODE 306
Read MoreIntravitreal anti-vascular endothelial growth factor (VEGF) therapy slows or stops damage that occurs in wet age-related macular degeneration (AMD), diabetic retinopathy (DR), and other retinal…
Read MoreThe Retinal Degeneration Fund (RD Fund), the venture philanthropy arm of The Foundation Fighting Blindness (FFB), recently launched the first company to come out of…
Read MoreMany medical device start-ups seek acquisition to secure the financial and operational resources they need to obtain regulatory approval and gain market access. Michael Gertner,…
Read MoreA growing number of people living past age 60 years, innovation to increase the effectiveness or accessibility of care, and competition are the largest factors…
Read MoreAll eyes turned to gene therapy for nine days in September, as three large pharmaceutical companies—AbbVie, Théa, and Novartis—initiated moves to foster the development of…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.